8988 related articles for article (PubMed ID: 1975566)
1. ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis.
Braakman E; Goedegebuure PS; Vreugdenhil RJ; Segal DM; Shaw S; Bolhuis RL
Int J Cancer; 1990 Sep; 46(3):475-80. PubMed ID: 1975566
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
3. The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
Ferrini S; Sforzini S; Cambiaggi A; Poggi A; Meazza R; Canevari S; Colnaghi MI; Moretta L
Int J Cancer; 1994 Mar; 56(6):846-52. PubMed ID: 7907079
[TBL] [Abstract][Full Text] [Related]
4. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
Quillet-Mary A; Cavarec L; Kermarrec N; Marchiol-Fournigault C; Gil ML; Conjeaud H; Fradelizi D
Int J Cancer; 1991 Feb; 47(3):473-9. PubMed ID: 1704356
[TBL] [Abstract][Full Text] [Related]
5. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
6. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
de Vries JE; Yssel H; Spits H
Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803
[TBL] [Abstract][Full Text] [Related]
7. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes.
Symington FW; Santos EB
J Immunol; 1991 Apr; 146(7):2169-75. PubMed ID: 1672345
[TBL] [Abstract][Full Text] [Related]
8. T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis.
Anichini A; Mortarini R; Alberti S; Mantovani A; Parmiani G
Int J Cancer; 1993 Apr; 53(6):994-1001. PubMed ID: 8097188
[TBL] [Abstract][Full Text] [Related]
9. Only dull CD3+ thymocytes bind to thymic epithelial cells. The binding is elicited by both CD2/LFA-3 and LFA-1/ICAM-1 interactions.
Nonoyama S; Nakayama M; Shiohara T; Yata J
Eur J Immunol; 1989 Sep; 19(9):1631-5. PubMed ID: 2477252
[TBL] [Abstract][Full Text] [Related]
10. ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes.
Hernandez-Caselles T; Rubio G; Campanero MR; del Pozo MA; Muro M; Sanchez-Madrid F; Aparicio P
Eur J Immunol; 1993 Nov; 23(11):2799-806. PubMed ID: 8223855
[TBL] [Abstract][Full Text] [Related]
11. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity.
Dohlsten M; Hedlund G; Lando PA; Trowsdale J; Altmann D; Patarroyo M; Fischer H; Kalland T
Eur J Immunol; 1991 Jan; 21(1):131-5. PubMed ID: 1671356
[TBL] [Abstract][Full Text] [Related]
12. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
13. Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules.
Weijtens ME; Willemsen RA; van Krimpen BA; Bolhuis RL
Int J Cancer; 1998 Jul; 77(2):181-7. PubMed ID: 9650549
[TBL] [Abstract][Full Text] [Related]
14. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
15. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.
Van Seventer GA; Shimizu Y; Horgan KJ; Shaw S
J Immunol; 1990 Jun; 144(12):4579-86. PubMed ID: 1972160
[TBL] [Abstract][Full Text] [Related]
16. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
17. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte function-associated antigen 1 is an activation molecule for human T cells.
Wacholtz MC; Patel SS; Lipsky PE
J Exp Med; 1989 Aug; 170(2):431-48. PubMed ID: 2569026
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against LFA-1 or its ligand ICAM-1 accelerate CD2 (T11.1 + T11.2)-mediated T cell proliferation.
Cerdan C; Lipcey C; Lopez M; Nunes J; Pierres A; Mawas C; Olive D
Cell Immunol; 1989 Oct; 123(2):344-53. PubMed ID: 2571421
[TBL] [Abstract][Full Text] [Related]
20. Membrane-bound anti-CD3 monoclonal antibodies trigger cytolytic T-lymphocyte-mediated tumor lysis.
Mentzer SJ; Wilson RE; Burakoff SJ; Herrmann SH
Arch Surg; 1988 Oct; 123(10):1280-5. PubMed ID: 3263103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
